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IMPACT OF OXYGEN CONTENT ON CHARACTERISTICS OF
MESENCHYMAL STEM CELLS ISOLATED FROM WHARTON'S JELLY
L. Reppel 1,2, T. Margossian 1, P. Moreau 3, N. Mercier 4,2, J.-F. Stoltz 1,5,
C. Huselstein 1,2, D. Bensoussan 1,5. 1CNRS - UMR 7561, Biopôle-Campus
Santé, Vandoeuvre-lès-Nancy, France; 2 Lorraine Univ., 54000 Nancy,
France; 3Commissariat à l'Energie Atomique/DSV/I2BM/Service de
Recherches en Hémato-Immunologie, IUH, Hôpital Saint-Louis, 75010 Paris,
France; 4 INSERM U684, Faculté de Médecine, Vandoeuvre-lès-Nancy,
France; 5CHU de Nancy Brabois, Unité de Thérapie Cellulaire et Tissulaire,
54511 Vandœuvre-lès-Nancy, France
Purpose: Mesenchymal stem cells from human Wharton's jelly (WJ-MSC)
represent an abundant and interesting source of stem cells for applications
in tissue engineering. Their fetal origin confers speciﬁc characteristics
compared to mesenchymal stem cells isolated from human bone marrow
(BM-MSC). The aim of this work is to carry out an accurate characterization
of WJ-MSC during their in vitro expansion which is a need for their use for
research and clinical applications to tissue and cell engineering. We focuse
on the impact of oxygen content during monolayer expansion.
Methods: WJ-MSC are isolated from umbilical cords by a non-enzymatic
method. Culture is performed until the seventh passage in normoxia (21%
of O2) or hypoxia (5% of O2). Different parameters are evaluated after P1, P3,
P5 and P7. Colony-forming units-ﬁbroblast (CFU-F) assays is performed to
evaluate the clonal expansion capacity of WJ-MSC. The proliferation is
evaluated by the population doubling time and the telomerase activity.
HLA-G molecule expression, related to immunomodulatory properties of
these cells, is assessed by qRT-PCR and also by ﬂow cytometry. After an
immunophenotype analysis of WJ-MSC by ﬂow cytometry, MSC are
directed towards the three ways of mesodermic differentiation which are
chondrogenesis, osteogenesis and adipogenesis. Finally, pluripotent stem
cell markers expression including Oct4, Sox2 and Nanog is performed by
qRT-PCR during expansion.
Results: Regardless of the passage, the low oxygen tension increases
proliferation capacity, signiﬁcantly decreases population doubling time of
WJ-MSC, and seems to increase HLA-G expression. Telomerase activity is
very low compared to HeLa cells (positive control) and no signiﬁcant
difference is observed between normoxia and hypoxia conditions. During
expansion, this activity is signiﬁcantly more important in P3 and P5 than in
P7 (p<0,001). Finally, according to histological labeling, hypoxia seems to
inhibit osteogenic differentiation and seems to be a contributing factor on
chondrogenesis. Regardless of culture conditions, adipogenic differentia-
tion of WJ-MSC seems difﬁcult to obtain.
Conclusions: Hypoxic conditions during WJ-MSC monolayer expansion
inﬂuence cell proliferation capacity and mesodermic differentiation
potential. Although WJ-MSC telomerase activity is detected, it remains
relatively low compared to positive control and decreases during expan-
ion. According to the use of WJ-MSC to tissue or cell engineering, it will be
necessary to adapt culture conditions and in particular the oxygen content.
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DIFFERENTIATION OF HUMAN ADULT MESENCHYMAL STEM CELLS IN
CHONDROCYTES FOR CARTILAGE ENGINEERING
D. Ollitrault, Jr. 1, F. Legendre, Jr. 1, T. Gomez-Leduc, Jr. 1, M. Hervieu, Jr. 1,
M. Bouyoucef, Jr.1, C. Drougard, Sr.1, F. Mallein-Gerin, Sr. 2, S. Leclercq,
Sr.1, K. Boumediene, Sr.1, M. Demoor, Sr.1, P. Galera, Sr.1. 1 Lab. of Cellular
microenvironnement and pathologies (MILPAT), Caen, France; 2 Lab. of
Biology and engineering of cartilage, CNRS FRE 3310, IBCP, Lyon, France
Purpose: Because articular cartilage has a poor intrinsic regeneration
ability, Autologous Chondrocytes Implantation (ACI) has emerged as an
alternative therapeutic strategy in cartilage healing after trauma or aged
related degeneration. The ﬁrst generation of ACI is limited by the dedif-
ferentiation process occurring during chondrocytes expansion, chon-
drocytes volume density being only 2%. In this context and to obtain
biological substitutes closely similar to hyaline cartilage, some upgrading
ACI are developed, using the therapeutic potential of mesenchymal stem
cells (MSCs). Thus, chondrocytes could be obtained from MSCs by chon-
drogenesis induction. Today, adult MSCs provide new hopes for theregenerative medicine, even if it seems that for one clinical application, all
MSCs are not suitable. In this study, we have developed a process allowing
MSCs from bone marrow to differentiate in chondrocytes able to synthe-
size matrix components characteristic of the hyaline cartilage.
Methods: Multipotent and immunophenotypically characterized MSCs
from bone marrow were ampliﬁed in monolayer cultures until 5 passages.
The differentiation step used an innovative approach combining 3D-
culture in type I collagen sponges, low oxygen tension and chondrogenic
factors (BMP-2 and TGF-ß1), their impact being sustained and improved by
RNA interference targeting two molecules whose expression is increased
in osteoarthritis.
Results: In this study, we have differentiated MSCs from bone marrow in
chondrocytes and these innovating results have led to an international
patent submission (patent request NPCT/FR2011/052198). Indeed, we
demonstrated that when we treated scaffold colonized by MSCs during 14
days in hypoxia, with chondrogenic factors and two siRNAs, we obtain
a chondrocyte phenotype, evaluated by 16 genes analysis (including
Integrin-ß1, SOX9, HIF-1a, HIF-2a, osteogenic markers and a new cartilage
marker), closely similar to the one observed in chondrocytes from healthy
cartilage. Our treatment allowed the increase of cartilage speciﬁc markers
such as type II collagen and aggrecan and the decrease of non speciﬁc
markers such as type III and type I collagens.
Conclusions: This work gives new insights in the molecular regulation
involved during the differentiation of MSCs in mature chondrocytes. This
approach could be better and could give more satisfactory results than
those observed with ACI. Preclinical-trials are planned in horses which
constitute an inescapable step to develop in the future, novel cell therapies
of articular defects in human.
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EFFECT OF ADIPOSE DERIVED STEM CELLS INJECTION IN AN
EXPERIMENTAL OSTEOARTHRITIS MODEL
G. Desando, B. Grigolo, C. Cavallo, C. Manferdini, G. Lisignoli, L. Martini,
F. Veronesi, A. Parrilli, M. Fini, R. Giardino, A. Facchini. Istituto Ortopedico
Rizzoli, Bologna, Italy
Purpose: The opportunity to enlarge the indications of autologous cell
transplantation to the treatment of degenerative changes in osteoarthritis
(OA) patients is very intriguing. Some interesting results have been
obtained by our Group by the implant of mesenchymal stem cells (MSCs) in
a rabbitmodel ofOA. Adiposederived stromal cells (ADSCs) are an attractive
source because of their plasticity, immuno-modulatory anti-ﬁbrotic prop-
erties, which render them appealing in the ﬁeld of cartilage tissue engi-
neering. For this reason, the aim of our study was to assess the efﬁcacy of
ADSC intra-articular injections in an experimental OA rabbit model.
Methods: 42 Adult male New Zealand rabbits were used. European and
Italian laws on animal experimentation were strictly followed throughout
the study. Rabbit knee joints were bilaterally subjected to Anterior Cruciate
Ligament Transection (ACLT) to surgically induce OA. After 8 weeks from
ACLT, the injured knees were treated with autologous 2.0x106 and 6.0x106
ADSC suspended in 4 % RSA (experimental group) or 4% RSA (control
group) by intra-articular injections. CM DiI labeling was used to evaluate
ADSC local biodistribution in vivo. Animals were sacriﬁed by means of an
intravenous lethal injection of Tanax at 2 and 4 months. Both femurs,
menisci and synovia were explanted and used to perform morphological
histomorphometric, histological, immunohistochemical and micro-CT
evaluations. Laverty's and Kraus’ Modiﬁed Mankin scoring systems were
used for histological assessment of osteoarthritis.
Results: Labeled ADSC were detected in the synovial tissue (in particular in
the synovial lining) and in the medial meniscus along all the specimen
thickness.Nocell engraftmentwasobserved in thearticularcartilage fromthe
medial and lateral femoral condyle and tibial plateau. At 8 weeks form ACLT,
structural alteration, superﬁcial ﬁbrillation, proteoglycan depletion, cluster
formation were observed in the cartilage of rabbit medial femoral condyles.
The treatment with both concentration of ADSC leaded, starting already at 2
months follow-up, to the regeneration of cartilage tissue with hyaline-like
aspect with smooth surface and high presence of proteoglycan component.
These featuresweremore evident in the joints that received the lowest ADSC
concentration with some differences between lateral and medial condyles.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S279Conclusions: Our data showed that OA defects, created by ACTL in a rabbit
model, were repaired with a new tissue after implantation of ADSC. The
morphological, histological immunohistochemical and Micro-CT data
conﬁrm in general the formation of cartilagewith some hyaline-like features
in the joints treated with the two different ADSC concentrations and partic-
ularly in the group treated with the low ADSC concentration particularly at
short time follow-up. Cell treatments seem to up-regulate the production of
collagen type II anddown-regulate thatof collagenType I,MMP-1andMMP-3
enzymes which are involved in catabolic processes. This work belongs to
a collaborative European Projectwithin the Seventh FrameWork Programme
“Adipose derived stromal cells for osteoarthritis treatment”.
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A LIVING HYALINE CARTILAGINOUS GRAFT FOR CARTILAGE TISSUE
ENGINEERING
K. Su, T. Lau, D.-A. Wang. Nanyang Technological Univ., Singapore, Singapore
Purpose: The objective of this study is to develop and apply an innovative,
tissue engineered, living hyaline cartilaginous graft (LhCG) that is free of
synthetic material components and composed of phenotypically bona ﬁde
hyaline cartilaginous neo-tissues. During the process of neo-tissue
formation in LhCG, an interim biomaterial based novel scaffolding system
plays an intermediate role before a complete removal prior to trans-
plantation. The social-economic importance of this work lies in contribu-
tion of a man-made living and qualiﬁed cartilaginous graft to make up for
the limited regenerations in this musculoskeletal tissue so that it may
substantially serve as a possible solution to the ailments faced by current
ageing population - particularly for regenerative treatment of osteoar-
thritis and other joint related disorders or lesions.
Methods: Technically, two steps of processes are performed for the prep-
aration of LhCG (as reported before). 1) Phase transfer cell culture (PTCC) in
hydrogel scaffold: microspherical pores are created in chondrocytes-
encapsulating alginate gel bulk via a controlled clearance of co-encapsu-
lated gelatin microspheres. By proliferative expansion, the encapsulated
chondrocytic isogenic groups adjacent to the gel/pore interface grow out of
gel phase and ﬁll up the pores, where neo-chondral nodules are formed.
And, 2) LhCG formation by hydrogel removal: expansion and fusion of PTCC
induced neo-tissue nodules within hydrogel bulk constructs macroscopic
3D network of a LhCG that interpenetrates the alginate scaffolds (gel) and
maintains structural integrity during the removal of alginate components
by a dissolving treatment with sodium citrate buffer.
Results: Successful fabrication of LhCG provides a scaffold-free porous
construct made of pure living cartilaginous tissues to act as a graft for
implantation. The results indicate that, by mediation within non-cell-
adhesive hydrogel scaffolds, the delivered chondrocytic phenotype is well
preserved from the very beginning to the end. This performance is
approved both in vitro and in vivo. In situ implantation in animal (rabbit
knee joint) models has demonstrated high success rates in both cartilage
repair and graft-host integration.
Conclusion: The results suggest that LhCG is a promising cartilaginous
graft for cartilage repair. Additionally, with a living tissue based nature,
LhCG may also play a role as a niche for multi-tissue regenerations as well
as an implantable transgenic platform for controlled release in situ.
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IN VITRO CARTILAGE TISSUE ENGINEERING WITH DIFFERENT TYPES OF
COLLAGEN POROUS SCAFFOLDS AND HUMAN BONE MARROW
MESENCHYMAL STEM CELLS
S. Díaz-Prado 1,2, E. Muiños-López 1, T. Hermida-Gómez 1, I. Fuentes-
Boquete 1,2, J. Buján 3, F. De Toro 1,2, F.J. Blanco 1. 1 INIBIC-CHUAC, A
Coruña, Spain; 2 INIBIC- Univ. of A Coruña, A Coruña, Spain; 3Dept. of Med.
Specialties. Univ. of Alcalá de Henares, Madrid, Spain
Purpose: To study the chondrogenic potential of human bone marrow
mesenchymal stem cells (hBM-MSCs) grown on different collagen scaf-
folds and to investigate the utility of these scaffolds to construct cartilage-
like tissue in vitro.
Methods: hBM-MSCs were isolated from human BM stroma and were
expanded in monolayer cultures. hBM-MSCs were characterized by ﬂowcytometryusing hematopoietic andMSCmarkers. At the 3-4th passage, hBM-
MSCs were cultured on different collagen supports. We tested four different
scaffolds: Col I+Col II+heparan sulfate; Col I+Col II+chondroitinsulfate; Col
I+heparin and Col I+chondroitinsulfate. The cell density over the supportwas
300.000cells/cm2. The studyperiodwas30days.hBM-MSCswere cultured in
chondrogenic differentiation medium (Lonza, Group Ltd, Switzerland).
Chondrogenic differentiation was conﬁrmed by histochemical and immu-
nohistochemical analysis. Transmission and scanning electronic microscopy
were performed to study the cell interior and cell morphology.
Results: hBM-MSCs were able to grow not only in the surface but also inside
thedifferent typesof collagen supports. Thepercentageof cells, regarding the
area of the analyzed support,washigher than75% in the Col I+Col II+ heparan
sulfate (Fig. 1A) and higher than 60% in the other scaffolds tested. Moreover,
good cell morphology and cell viability were observed in all the scaffolds
studied. hBM-MSCs showed the formation of cell aggregates with chon-
drocyte-like morphology and produced an extracellular matrix around cells.
At the sametimethathBM-MSCsproliferatedover thesupport theywereable
to degrade the scaffold. Moreover, cellular anchors were observed on the
support (Fig. 1B). hBM-MSCs grown in chondrogenic medium were able to
differentiate into cells that showedcharacteristics similar to chondrocytes. To
demonstrate the chondrogenic differentiation some immunostainings were
performed in order to detect the presence of different characteristic
components of the articular cartilage. As it is shown in ﬁgure 1C and D, the
cells showedpositive immunostaining for type II collagenandoneof themost
abundant proteoglycanof cartilage (aggrecan). Scanningelectronmicroscopy
(Fig.1E) allowedus to study the structure and the porosity of the support and
to observe, with high magniﬁcation, cellular adhesion and morphology.
Transmission electron microscopy (Fig. 1F) showed that cells had large
number of lipid vacuoles and the accumulation of glycogen. Moreover, they
wereembedded inthescaffoldsand theyshowedmanyextensions for secrete
adhesion molecules useful to adhere to the support. In general, there were
cells with large cytoplasm and with a high secretory activity.
Conclusions: Our data demonstrated that these different collagen scaf-
folds were optimal for hBM-MSCs growth. Furthermore, hBM-MSCs
cultured in chondrogenic medium over these scaffolds were able to
differentiate into chondrocyte-like cells and to synthesize extracellular
matrix. These supports are suitable candidates as an alternative cell-carrier
for cartilage tissue engineering since chondrogenic hBM-MSCs and
collagen scaffolds may be used to construct cartilage-like tissue in vitro.
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